Research News

New molecule formed during omega-3 fatty acids metabolism in body may inhibit cancer

  • Posted on: 17 July 2018
  • By: PharmaTutor News

A class of molecules formed when the body metabolizes omega-3 fatty acids could inhibit cancer's growth and spread, University of Illinois researchers report in a new study in mice. The molecules, called endocannabinoids, are made naturally by the body and have similar properties to cannabinoids found in marijuana - but without the psychotropic effects.

Anti obesity drug derived from chilly seems effective

  • Posted on: 17 July 2018
  • By: PharmaTutor News

A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet, in new studies from the University of Wyoming School of Pharmacy. The drug, Metabocin, was designed to slowly release capsaicin throughout the day so it can exert its anti-obesity effect without producing inflammation or adverse side effects.

Fasting can be additional treatment to multiple sclerosis?

  • Posted on: 10 July 2018
  • By: PharmaTutor News

People with multiple sclerosis (MS) can find an abundance of conflicting advice suggesting that special diets - everything from avoiding processed foods to going low-carb - will ease their symptoms. But the evidence is scanty that dietary changes can improve fatigue or other MS symptoms.

New insight into Huntington's disease may open door to drug development : Researchers

  • Posted on: 10 July 2018
  • By: PharmaTutor News

McMaster University researchers have developed a new theory on Huntington's disease which is being welcomed for showing promise to open new avenues of drug development for the condition.  Huntington's disease is caused by a mutation in the gene that makes the protein called huntingtin.

Does HPV vaccination prevent the development of cervical cancer?

  • Posted on: 10 May 2018
  • By: PharmaTutor News

Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials.

The combination of Anti-HIV drug does not raise preterm birth problems: study says

  • Posted on: 30 April 2018
  • By: Shalini.Sharma

A drug combination aimed at preventing transmission of HIV from a pregnant woman to her fetus likely does not increase the risk for preterm birth and early infant death, according to a re-analysis of two studies funded by the National Institutes of Health. The research appears in the New England Journal of Medicine.

Pages